3 weeks Wall Street Analysts See a 52.15% Upside in CorMedix (CRMD): Can the Stock Really Move This High?Zacks
The consensus price target hints at a 52.2% upside potential for CorMedix (CRMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
X